Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASIS

Rheumatology (United Kingdom)

Volumn 54, Issue 4, 2014, Pages 633-640

  Essers, Ivette ^a,b   Ramiro, Sofia ^c,d   Stolwijk, Carmen ^a,b   Blaauw, Marc ^e   Landewé, Robert ^d,f   Van Der Heijde, Désirée ^g   Van Den Bosch, Filip ^h   Dougados, Maxime ⁱ   Van Tubergen, Astrid ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d HOSPITAL GARCIA DE ORTA   (Portugal)

^e CATHARINA HOSPITAL   (Netherlands)

^f Zuyderland Medical Centre   (Netherlands)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h GHENT UNIVERSITY HOSPITAL   (Belgium)

ⁱ UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Ankylosing spondylitis; Anterior uveitis; Inflammatory bowel disease; Psoriasis

Indexed keywords

C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HLA B27 ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGE; ANKYLOSING SPONDYLITIS; ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; COHORT ANALYSIS; DEMOGRAPHY; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; INFLAMMATORY BOWEL DISEASE; INTERRATER RELIABILITY; INTRARATER RELIABILITY; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; SPINAL PAIN; SPINE RADIOGRAPHY; WELLBEING;

EID: 84926465644     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu388     Document Type: Article

References (31)

1. Baraliakos X, Braun J. Spondyloarthritides. Best Pract Res Clin Rheumatol 2011;25:825-42.
2. Elewaut D, Matucci-Cerinic M. Treatment of ankylosing spondylitis and extra-articular manifestations in everyday rheumatology practice. Rheumatology 2009;48:1029-35.
3. Stolwijk C, van Tubergen A, Castillo-Ortiz JD, Boonen A. Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and metaanalysis. Ann Rheum Dis 2013; doi:10.1136/annrheumdis-2013-203582.
4. van der Horst-Bruinsma IE, Nurmohamed MT, LandewéRBM. Comorbidities in patients with spondyloarthritis. Rheum Dis Clin North Am 2012;38:523-38.
5. El Maghraoui A. Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med 2011;22:554-60.
6. Zeboulon N, Dougados M, Gossec L. Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review. Ann Rheum Dis 2008;67:955-9.
7. Rudwaleit M, Baeten D. Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol 2006;20:451-71.
8. Van Praet L, Van den Bosch FE, Jacques P et al. Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model. Ann Rheum Dis 2013;72:414-7.
9. Garrett S, Jenkinson T, Kennedy LG et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
10. Lavie F, Salliot C, Dernis E et al. Prognosis and follow-up of psoriatic arthritis with peripheral joint involvement: development of recommendations for clinical practice based on published evidence and expert opinion. Joint Bone Spine 2009;76:540-6.
11. Richette P, Tubach F, Breban M et al. Psoriasis and phenotype of patients with early inflammatory back pain. Ann Rheum Dis 2013;72:566-71.
12. Machado P, LandewéR, Braun J et al. Ankylosing spondylitis patients with and without psoriasis do not differ in phenotype. Ann Rheum Dis 2013;72:1104-7.
13. Braun J, Baraliakos X, Listing J et al. Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents. Arthritis Rheum 2007;57:639-47.
14. Toussirot E, Houvenagel E, Goeb V et al. Development of inflammatory bowel disease during anti-TNF-alpha therapy for inflammatory rheumatic disease: a nationwide series. Joint Bone Spine 2012;79:457-63.
15. Rudwaleit M, van der Heijde D, Khan M, Braun J, Sieper J. How to diagnose axial spondyloarthritis early. Ann Rheum Dis 2004;63:535-43.
16. Rudwaleit M, van der Heijde D, Landewe R et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68:777-83.
17. Rudwaleit M, van der Heijde D, Landewe R et al. The Assessment in SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011;70:25-31.
18. Goie The HS, Steven MM, van der Linden SM, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis:a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Br J Rheumatol 1985;24:242-9.
19. Lukas C, Landewe R, Sieper J et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009;68:18-24.
20. Calin A, Garrett S, Whitelock H et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
21. Jenkinson TR, Mallorie PA, Whitelock HC et al. Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 1994;21:1694-8.
22. Jones SD, Steiner A, Garrett SL, Calin A. The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol 1996;35:66-71.
23. Creemers MC, Franssen MJ, van't Hof MA et al. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 2005;64:127-9.
24. Ramiro S, Stolwijk C, van Tubergen A et al. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study. Ann Rheum Dis 2013; doi:10.1136/annrheumdis-2013-204055.
25. de Vet HCW. Reliability. In: de Vet HCW, ed. Measurement in Medicine: A Practical Guide. Cambridge. UK:Cambridge University Press, 2011:115-9.
26. Linssen A, Rothova A, Valkenburg HA et al. The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibility antigen HLA-B27. Invest Ophthalmol Vis Sci 1991;32:2568-78.
27. Plunkett A, Marks R. A review of the epidemiology of psoriasis vulgaris in the community. Australas J Dermatol 1998;39:225-32.
28. Molodecky NA, Soon IS, Rabi DM et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46-54, e42; quiz e30.
29. Landewe R, Dougados M, Mielants H, van der Tempel H, van der Heijde D. Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine. Ann Rheum Dis 2009;68:863-7.
30. Dougados M, d'Agostino MA, Benessiano J et al. The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients. Joint Bone Spine 2011;78:598-603.
31. Rudwaleit M, Haibel H, Baraliakos X et al. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 2009;60:717-27.